Entrada Therapeutics
(NASDAQ) TRDA
Entrada Therapeutics Financials at a Glance
Market Cap
$265.53M
Revenue (TTM)
$5.74M
Net Income (TTM)
$166.12M
EPS (TTM)
$-4.00
P/E Ratio
-1.71
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.84
Volume
46,232
Open
$6.56
Price
$6.84
Volume
46,232
Open
$6.56
Previous Close
$6.84
Daily Range
$6.02 - $6.86
52-Week Range
$4.93 - $16.45
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.84
Volume
46,232
Open
$6.56
Previous Close
$6.84
Daily Range
$6.02 - $6.86
52-Week Range
$4.93 - $16.45
TRDA News
TRDA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Entrada Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
152
CEO
Dipal Doshi, MBA
Website
www.entradatx.comHeadquarters
Boston, MA 02210, US
TRDA Financials
Key Financial Metrics (TTM)
Gross Margin
-6%
Operating Margin
-31%
Net Income Margin
-29%
Return on Equity
-48%
Return on Capital
-56%
Return on Assets
-50%
Earnings Yield
-58.48%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$265.53M
Shares Outstanding
38.82M
Volume
46.23K
Avg. Volume
287.88K
Financials (TTM)
Gross Profit
$21.32M
Operating Income
$156.00M
EBITDA
$142.40M
Operating Cash Flow
$128.51M
Capital Expenditure
$1.04M
Free Cash Flow
$129.55M
Cash & ST Invst.
$295.70M
Total Debt
$50.93M
Entrada Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$875.00K
-95.7%
Gross Profit
$70.00K
-99.7%
Gross Margin
8.00%
N/A
Market Cap
$265.53M
N/A
Market Cap/Employee
$1.45M
N/A
Employees
183
N/A
Net Income
$39.72M
-128.9%
EBITDA
$42.30M
-103.0%
Quarterly Fundamentals
Net Cash
$205.11M
-37.0%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$45.47M
-9.9%
Short Term Debt
$4.28M
-34.2%
Return on Assets
-49.51%
N/A
Return on Invested Capital
-56.40%
N/A
Free Cash Flow
$41.74M
-5.3%
Operating Cash Flow
$41.70M
-8.3%